Literature DB >> 21115545

Pathogenesis of postoperative recurrence in Crohn's disease.

Tasneem Ahmed1, Florian Rieder, Claudio Fiocchi, Jean-Paul Achkar.   

Abstract

The majority of patients with Crohn's disease (CD) require surgery during the course of their disease, but such surgery is typically not curative. Although some studies suggest that the disease state is theoretically reset to its earliest phase following surgery, disease phenotype and natural history of CD do not change significantly after surgery, leading to high rates of recurrence. Factors predisposing to this recurrence are not well defined, so there is a need for and a unique opportunity to develop a better understanding of the pathogenesis of recurrent inflammation and associated risk factors after an ileocolic resection. This paper reviews the postoperative disease outcome and evolution based on defining the combination of the patient's microbial flora, environmental exposure history, immune response and genetic make-up.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21115545     DOI: 10.1136/gut.2010.221705

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  13 in total

1.  A survey of current practices used to maintain surgically induced remission following intestinal resection for Crohn's disease.

Authors:  John P Burke; Glen A Doherty; P Ronan O'Connell
Journal:  Int J Colorectal Dis       Date:  2013-03-09       Impact factor: 2.571

2.  Postoperative Medical Management of Crohn's Disease: Prevention and Surveillance Strategies.

Authors:  Miguel Regueiro; Scott A Strong; Linda Ferrari; Alessandro Fichera
Journal:  J Gastrointest Surg       Date:  2016-05-26       Impact factor: 3.452

3.  Murine ileocolic bowel resection with primary anastomosis.

Authors:  Troy Perry; Anna Borowiec; Bryan Dicken; Richard Fedorak; Karen Madsen
Journal:  J Vis Exp       Date:  2014-10-29       Impact factor: 1.355

Review 4.  Tailored Medical Management of the Complex Postoperative Crohn's Disease Patient.

Authors:  Jean-Paul Achkar
Journal:  Clin Colon Rectal Surg       Date:  2019-07-02

5.  Perioperative Blood Transfusion and Postoperative Outcome in Patients with Crohn's Disease Undergoing Primary Ileocolonic Resection in the "Biological Era".

Authors:  Yi Li; Luca Stocchi; Yuanyi Rui; Ganglei Liu; Emre Gorgun; Feza H Remzi; Bo Shen
Journal:  J Gastrointest Surg       Date:  2015-08-19       Impact factor: 3.452

6.  Adalimumab in prevention of postoperative recurrence of Crohn's disease in high-risk patients.

Authors:  Mariam Aguas; Guillermo Bastida; Elena Cerrillo; Belén Beltrán; Marisa Iborra; Cristina Sánchez-Montes; Fernando Muñoz; Jesús Barrio; Sabino Riestra; Pilar Nos
Journal:  World J Gastroenterol       Date:  2012-08-28       Impact factor: 5.742

7.  Comparison of the effectiveness of infliximab and adalimumab in preventing postoperative recurrence in patients with Crohn's disease: an open-label, pilot study.

Authors:  A Tursi; W Elisei; M Picchio; C Zampaletta; G Pelecca; R Faggiani; G Brandimarte
Journal:  Tech Coloproctol       Date:  2014-06-12       Impact factor: 3.781

8.  Mesenteric Lymphatic Vessel Density Is Associated with Disease Behavior and Postoperative Recurrence in Crohn's Disease.

Authors:  Yi Li; Yuanyuan Ge; Jianfeng Gong; Weiming Zhu; Lei Cao; Zhen Guo; Lili Gu; Jieshou Li
Journal:  J Gastrointest Surg       Date:  2018-07-24       Impact factor: 3.452

9.  Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease.

Authors:  R Kiesslich; C A Duckworth; D Moussata; A Gloeckner; L G Lim; M Goetz; D M Pritchard; P R Galle; M F Neurath; A J M Watson
Journal:  Gut       Date:  2011-11-24       Impact factor: 23.059

10.  Contribution of intestinal smooth muscle to Crohn's disease fibrogenesis.

Authors:  C Severi; R Sferra; A Scirocco; A Vetuschi; N Pallotta; A Pronio; R Caronna; G Di Rocco; E Gaudio; E Corazziari; P Onori
Journal:  Eur J Histochem       Date:  2014-12-17       Impact factor: 3.188

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.